RETA
Reata Pharmaceuticals Inc
Chief Commercial Officer Dawn Carter Bir sold $191K of Reata Pharmaceuticals Inc
Sold$191,148
$88.25Price
2,166Shares
−4%Stake
What RETA did after the filing
- The stock from Mon, Mar 6 close, $88.51
- +12.0%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 18 close.
Traded Fri, Mar 3. Filed Mon, Mar 6, 11:28 AM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.